PTEN and type 2 diabetes mellitus: While none of the targets were experimentally verified in all four diseases, we found that PTEN was targeted in atherosclerosis, NAFLD and T2DM/IR, while ETS1 was targeted in atherosclerosis, obesity and T2DM/IR (Figure 4B).